A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

NCT03482024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency
End Stage Renal Disease

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company